An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.
Related Posts
How to safely store medicine — and when you should throw it away
- blkalertshealth
- April 20, 2024
- 0
Family medicine physician Dr.
Scientists Find New Genetic Variants for Obesity
- blkalertshealth
- April 5, 2024
- 0
Researchers believe they have discovered a